USPTO serial 99677708
KLONA BIOTECH
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- OROSS, JILLIAN E
- Law office
- TMO LAW OFFICE 134
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with KLONA BIOTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New Castle County, DE, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Connie L. Ellerbach
Connie L. Ellerbach Fenwick & West LLP801 California St.Mountain View, CA 94041United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological and chemical compositions in the nature of biological and chemical preparations for use in scientific and laboratory research; polymer-based and hydrogel-based compositions for use in the manufacture of commercial, industrial and domestic goods for three-dimensional (3D) bioprinting for scientific use; unprocessed bioinks comprised of natural and synthetic polymers for scientific and research use; chemical reagents for scientific purposes, namely, chemical reagents for use in tissue engineering and regenerative medicine research; cell culture media and cell growth supplements for scientific laboratory use; scaffold materials in the nature of chemical preparations for use in biofabrication and tissue engineering for scientific purposes; biological preparations for use in industry and science, namely, extracellular matrix (ECM) compositions for scientific and research use; biological preparations for scientific purposes, namely, collagen and gelatin-based biomaterials for scientific purposes; chemical additives in the nature of chemical substrates and support materials for use in additive manufacturing of biological structures | PARTIALLY PAID | — |
| 002 | Ink cartridges, filled, specially adapted for medical bioprinters | PARTIALLY PAID | — |
| 005 | Bioinks comprised primarily of biological materials for medical use; biological preparations for tissue engineering for medical purposes; engineered biological tissue cultures for regenerative medicine for medical purposes; living tissue constructs for medical use; implantable biological scaffolds comprising living tissue for maintaining tissue contour for medical use; biomaterial matrices for medical use for tissue repair and regeneration; sterile biofabricated tissues for surgical implantation; regenerative medicine products, namely, engineered biological tissue grafts | PARTIALLY PAID | — |
| 007 | Three-dimensional (3D) bioprinters for medical use; printer heads and cartridges specially adapted for 3D medical bioprinters; 3D bioprinters in the nature of tissue printing machines for medical applications; 3D printers containing sterile printing chambers for medical bioprinting; Medical devices in the nature of 3D bioprinters for printing biological tissues and cellular structures; biofabrication apparatus in the nature of 3D bioprinters for creating living tissues for medical purposes | PARTIALLY PAID | — |
| 009 | Downloadable software for controlling and operating three-dimensional (3D) bioprinters and biofabrication systems; downloadable software for designing and modeling biological structures for printing; downloadable software for processing and preparing biofabrication print files; downloadable software for monitoring and controlling biofabrication processes; downloadable computer software platforms for managing biological printing workflows; recorded operating software, capable of functioning offline, for slicing and controlling bioprinting apparatus | PARTIALLY PAID | — |
| 010 | medical instruments for dispensing and depositing bioinks and biomaterials | PARTIALLY PAID | — |
| 040 | Custom manufacturing of biological tissues and tissue constructs for others using three-dimensional (3D) bioprinting; custom contract 3D bioprinting services for the production of biological materials and engineered tissues for others; custom fabrication of biomaterial scaffolds for third parties; custom additive manufacturing services in the field of biofabrication, for others; custom manufacture of hydrogel and polymer biological structures for research and medical applications; bioprinting services, namely, fabrication of biological constructs in the nature of bioprinted medical implants to order for others | PARTIALLY PAID | — |
| 042 | Scientific research and development in the field of three-dimensional (3D) bioprinting and biofabrication; scientific and technological services, namely, research and design of bioinks and biomaterials; product development in the field of tissue engineering and regenerative medicine; laboratory research services relating to engineered tissues and biological structures; design and testing of new products, namely, bioprinting materials, for others; biomedical research services; engineering and technical consulting services in the field of biological printing systems; development of quality control standards for custom biofabrication and printing for others | PARTIALLY PAID | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Klona Biotech Inc.
- Other trademarks in Class 001
- Other trademarks in Class 002
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named KLONA BIOTECH
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 22, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 23, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 23, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 23, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 12, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 12, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 12, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 6, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 6, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 6, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 28, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 2, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 2, 2026 | NWAP | NEW APPLICATION ENTERED | — |